Clinical Trials Browser

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT06624189 2026-02-27

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Enrolling by invitation

1,300 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Enrolling by invitation

100 enrolled

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

1,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07158450 2026-02-25

NOECHO

Enrolling by invitation

50 enrolled

Heart Failure, Cardiotoxicity

NCT07400835 2026-02-24

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Enrolling by invitation

600 enrolled

Gynecologic

Endometrial Neoplasms

NCT05369611 2026-02-19

COVID-19 Experiences in the SELF Cohort

Enrolling by invitation

1,668 enrolled

COVID-19, Leiomyoma

NCT06412029 2026-02-19

HRSN

Enrolling by invitation

144 enrolled

Tumor-Agnostic

Neoplasms

NCT04693754 2026-02-18

EUS-RFA

Enrolling by invitation

100 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07417774 2026-02-18

RESTORE LB

Enrolling by invitation

40 enrolled

CNS

Glioblastoma

NCT00001620 2026-02-17

Screening for Hematology Branch Protocols

Enrolling by invitation

10,000 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT01382082 2026-02-17

CANTAB

Enrolling by invitation

1,432 enrolled

BreastLymphoid

Breast Neoplasms, Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Clinical Trials

Development and Application of Patient-Derived Models of Cancer

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

PERSIST

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy

LTFS

Harvesting Cells for Experimental Cancer Treatments

ablation IN BE

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

OPTIMA

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

CPHMS

AFFEPAM

CONQUER

LEO

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NOECHO

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

COVID-19 Experiences in the SELF Cohort

HRSN

EUS-RFA

RESTORE LB

Screening for Hematology Branch Protocols

CANTAB

Pathogenesis of Hematologic Malignancies